Despite the many links between myeloperoxidase (MPO), oxidant stress, and the evolution of atherosclerotic coronary artery disease (CAD), many critical questions remain. For example, a direct demonstration of a causal role for MPO in atherosclerotic CAD in humans is not yet established. Moreover, mechanisms for regulating MPO in vivo remain unknown. The present application represents a logical progression of our studies and a direct effort to address these important questions. It is predicated upon the hypothesis that MPO and its newly discovered interactions with the HDL associated protein paraoxonase 1 (PON1) are genetically and mechanistically linked to oxidative stress and the development of cardiovascular disease. It integrates studies on basic mechanisms of action, interaction and molecular structure along with a search for specific reaction products to reveal whether relevant pathways operate in human disease, and in animal models of inflammation and cardiovascular disorders. The overall goals of this proposal are to: (i) define at both the structural and functional level MPO interactions with the HDL associated protein P0N1 and the reciprocal effects of MPO and PON1 on the regulation of each other's catalytic activity;and (ii) use a combination of genetic and biochemical approaches to explore the role of MPO, PON1 and specific oxidation pathways in development of CVD. We will achieve this through the following specific aims:
Aim 1) We will testing the hypothesis that MPO, HDL and PON1 form a functional ternary complex that plays a role in the reciprocal regulation of MPO and PON1 activities in vivo.
Aim 2) We will test the hypothesis that genetic and biochemical determinants of MPO and PON1 are linked to oxidant stress and coronary atherosclerotic plaque development, progression and adverse cardiac events in vivo. Collectively, the proposed studies represent an integrated, multidisciplinary and systematic approach designed to elaborate mechanisms linking MPO, oxidant stress and atherogenesis. The proposed studies will provide new insights into clinically important questions investigating a potential causal role of MPO and oxidant stress in atherogenesis. Successful completion of these studies will help discover key structural and functional relationships linking MPO with risks for development of prevalent cardiovascular disease, plaque progression and major adverse cardiovascular events.

Public Health Relevance

The proposed studies will also provide new insights into how a key protein found in white blood cells, myeloperoxidase (MPO), contributes to oxidative stress and inflammatory injury within the coronary vessel wall. These studies will also help identify new diagnostic tests for heart disease risk prediction, and potential therapeutic targets for treatment and prevention of heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL076491-06A1
Application #
7793867
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2009-12-01
Project End
2014-11-30
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
6
Fiscal Year
2010
Total Cost
$382,160
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Arif, Abul; Terenzi, Fulvia; Potdar, Alka A et al. (2017) EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Nature 542:357-361
Arif, Abul; Jia, Jie; Halawani, Dalia et al. (2017) Experimental approaches for investigation of aminoacyl tRNA synthetase phosphorylation. Methods 113:72-82
Senthong, Vichai; Wu, Yuping; Hazen, Stanley L et al. (2017) Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index. Am Heart J 184:17-25
Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M et al. (2017) The extreme C-terminal region of kindlin-2 is critical to its regulation of integrin activation. J Biol Chem 292:14258-14269
Zewinger, Stephen; Kleber, Marcus E; Tragante, Vinicius et al. (2017) Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol 5:534-543
Arif, Abul; Yao, Peng; Terenzi, Fulvia et al. (2017) The GAIT translational control system. Wiley Interdiscip Rev RNA :
Brown, J Mark; Hazen, Stanley L (2017) Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery. J Biol Chem 292:8560-8568
Pamir, Nathalie; Hutchins, Patrick M; Ronsein, Graziella E et al. (2017) Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight 2:
Mollenhauer, Martin; Friedrichs, Kai; Lange, Max et al. (2017) Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling. Circ Res 121:56-70
Tang, W H Wilson; Wang, Zeneng; Li, Xinmin S et al. (2017) Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clin Chem 63:297-306

Showing the most recent 10 out of 262 publications